Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1942-1961
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Figure 7 Effects of Buqing granule on retinal morphology in diabetic retinopathy rats.
A: Hematoxylin & eosin staining of the retina of rats in each group (400 ×); B: Retinal ganglion cell count in each group; C: Comparison of retinal thickness in each group. The sequence from left to right represents the control group, the model group, the Buqing granule group and the Calcium dobesilate group. aP < 0.05, bP < 0.01, cP < 0.001. BQKL: Buqing granule; CaD: Calcium dobesilate. GCL: Ganglion cell layer; IPL: Inner plexiform layer; INL: Inner nuclear layer; OPL: Outer plexiform layer; ONL: Outer nuclear layer.
- Citation: Yang YF, Yuan L, Li XY, Liu Q, Jiang WJ, Jiao TQ, Li JQ, Ye MY, Niu Y, Nan Y. Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation. World J Diabetes 2024; 15(9): 1942-1961
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1942.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1942